INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,690,000 | +225.6% | 153,788 | +172.4% | 0.00% | +100.0% |
Q4 2016 | $519,000 | -29.1% | 56,455 | -9.1% | 0.00% | 0.0% |
Q3 2016 | $732,000 | -22.2% | 62,122 | -14.5% | 0.00% | -50.0% |
Q2 2016 | $941,000 | -23.6% | 72,697 | -6.2% | 0.00% | -33.3% |
Q1 2016 | $1,231,000 | – | 77,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |